The latest closing stock price for Inozyme Pharma as of November 20, 2024 is 2.79.
An investor who bought $1,000 worth of Inozyme Pharma stock at the IPO in 2020 would have $-841 today, roughly -1 times their original investment - a -36.85% compound annual growth rate over 4 years.
The all-time high Inozyme Pharma stock closing price was 30.20 on September 01, 2020.
The Inozyme Pharma 52-week high stock price is 7.79, which is 179.2% above the current share price.
The Inozyme Pharma 52-week low stock price is 2.69, which is 3.6% below the current share price.
The average Inozyme Pharma stock price for the last 52 weeks is 4.96.
An investor who bought $1,000 worth of Inozyme Pharma stock at the IPO in 2020 would have $-841 today, roughly -1 times their original investment - a -36.85% compound annual growth rate over 4 years.
The all-time high Inozyme Pharma stock closing price was 30.20 on September 01, 2020.
The Inozyme Pharma 52-week high stock price is 7.79, which is 179.2% above the current share price.
The Inozyme Pharma 52-week low stock price is 2.69, which is 3.6% below the current share price.
The average Inozyme Pharma stock price for the last 52 weeks is 4.96.